期刊文献+

急性髓细胞白血病患儿骨髓单个核细胞中自分泌运动因子受体表达的检测 被引量:3

Detection of autocrine motility factor receptor in bone marrow mononuclear cells from children with acute myelogenous leukemia
下载PDF
导出
摘要 目的:通过检测自分泌运动因子受体(AMFR)在急性髓细胞白血病(AML)患儿骨髓单个核细胞中的表达情况,探讨其与AML化疗缓解率的关系。方法:采用RT-PCR及Western blot方法检测试验组(63例AML患儿)与对照组(50例非AML患儿)骨髓单个核细胞中AMFR mRNA及蛋白的表达水平,其中试验组包括AML初治患儿35例、完全缓解患儿18例、复发患儿10例,分析AMFR mRNA表达与缓解率的关系。结果:1AMFR mRNA及蛋白表达水平在对照组、缓解组、初治组及复发组中逐渐升高(F=13.105、10.010,P均<0.001),组间两两比较差异均有统计学意义(P均<0.05)。2AMFR mRNA高表达患儿的缓解率为15%,低于AMFR mRNA低表达患儿的缓解率84%(χ2=21.254,P<0.001)。结论:AMFR在儿童AML中存在高表达,AMFR可作为化疗敏感性及预后判断的指标。 Aim: To investigate the autocrine motility factor receptor( AMFR) expression in childhood acute myelogenous leukemia( AML) and the relationship between the expression and clinical remission rate.Methods: The levels of AMFR protein and mRNA in 63 cases of AML children( including 35 cases diagnosed newly,18 cases with complete remission,and 10 cases suffered from the recurrence of AML) and 50 controls were detected by RT-PCR and Western blot,and the relationship between the expression of AMFR mRNA and the remission rate of AML was analyzed.Results: The expression level of AMFR mRNA and protein in the control group,the untreated group,the complete remission group,and the relapse group increased significantly in turn( F = 13.105,10.010,P〈 0.001).There were significant differences between each 2 groups among the 4 groups( P〈 0.05).The remission rate of children with lower AMFR mRNA expression( 84%)was significantly higher than those with higher AMFR mRNA expression( 15%)( χ2= 21.254,P〈 0.001).Conclusion:There is an overexpression of AMFR in childhood AML.AMFR could be used as an important indicator for judging the prognosis and chemotherapy sensitivity of AML.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2015年第1期121-124,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 自分泌运动因子受体 急性髓细胞白血病 儿童 autocrine motility factor receptor acute myelogenous leukemia children
  • 相关文献

参考文献10

二级参考文献45

  • 1王伟,杨连粤,杨治力,黄耿文,鲁伟群.自分泌运动因子受体和RhoC基因在肝细胞癌侵袭转移中的作用[J].中华肝胆外科杂志,2004,10(6):408-410. 被引量:4
  • 2Endo K, Shirai A, Furukawa M, et al. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma[J]. Hum Pathol,2006,37 (8) :1111 -6.
  • 3Dong G, Lee T L, Yeh N T, et al. Metastatic squamous cell carcinoma cells that overexpress C-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor[ J]. Oncogene,2004,23 ( 37 ) :6199 - 208.
  • 4Wang W, Yang L Y, Yang Z L, et al. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma [J]. Dig Dis Sci,2007,52(3) :770 -5.
  • 5Yanagawa T, Funasaka T, Tsutsumi S, et al. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy[J]. Endocr Relat Cancer,2004,11 (4) :749 - 59.
  • 6Jiang W G, Raz A, Douglas-Jones A, et al. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer [ J ]. J Histochem Cytochem ,2006,54 ( 2 ) 231 - 41.
  • 7Royal I, Lamarche-Vane N, Lamorte L, et al. Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation [ J ]. Mol Biol Cell,2000,11 (5) : 1709 - 25.
  • 8Yoshizali T, Maruyama Y, Sato H, et al. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma[ J ]. Int J Cancer,2001,95 ( 1 ) :44 - 50.
  • 9Ma P C, Schaefer E, Christensen J G, et al. A selective small molecule C-Met Inhibitor, PHA665752, cooperates with rapamycin [ J ]. Clin Cancer Res,2005,11 ( 6 ) :2312 - 9.
  • 10Liotta LA, Maudler R, Murano G, et al. Tumor cell antocrine motility factor[ J ]. Proc Natl Acad Sci USA, 1986,83 (10) :3 302.

共引文献26

同被引文献22

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部